KOBO BIOTECH LIMITED
Latest filings
- NCLT appoints new Chairman of Kobo Biotech Monitoring Committee · Regulatory & Legal
- RTA submits Q2 FY27 demat compliance certificate to BSE · Compliance
- 32nd AGM held via video conferencing; annual accounts adopted with 100% approval · Board & Shareholder Meetings
Snapshot
What the business is, and whether it's a good one at a fair price.
A Chemicals & Petrochemicals company listed on BSE, reporting revenue of ₹0 Cr over the trailing twelve months.
Scorecard
Measured from the filed financials, judged against its Commodity Chemicals peers · as of FY24 — not investment advice
Strengths
Concerns
Charts
How has the market priced it — with filings on the timeline?
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from KOBO BIOTECH LIMITED's filed financials and exchange disclosures
What does KOBO BIOTECH LIMITED do?
KOBO BIOTECH LIMITED is a Chemicals & Petrochemicals company listed on BSE.
Is KOBO BIOTECH LIMITED profitable?
No. Over the trailing twelve months KOBO BIOTECH LIMITED reported a net loss of ₹5.03 Cr with no revenue reported.
Does KOBO BIOTECH LIMITED pay a dividend?
Not in the latest reported year — KOBO BIOTECH LIMITED's dividend payout for FY24 was nil.
Is KOBO BIOTECH LIMITED debt-free?
No. It reported borrowings of ₹140 Cr on its 31 Mar 2024 balance sheet, or net debt of ₹140 Cr after cash. Its net worth is negative — liabilities exceed assets by ₹133 Cr, so a debt-to-equity ratio is not meaningful.
How much does the KOBO BIOTECH LIMITED share price move in a day?
On a typical session KOBO BIOTECH LIMITED moves 3.10% — that is the median absolute close-to-close move across its last 236 trading days. MarketPing measures each filing's price reaction against it.
Where can I track KOBO BIOTECH LIMITED's announcements?
Every NSE and BSE filing by KOBO BIOTECH LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.